Can pulmonary artery hypertension be attributed to levosimendan? A problematic based on a patient's case

J Cardiovasc Med (Hagerstown). 2010 Jul;11(7):552-3. doi: 10.2459/JCM.0b013e32833668a9.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Comment

MeSH terms

  • Aged
  • Aortic Valve Stenosis / complications
  • Aortic Valve Stenosis / surgery
  • Blood Pressure / drug effects*
  • Cardiotonic Agents / administration & dosage
  • Cardiotonic Agents / adverse effects*
  • Coronary Artery Bypass
  • Coronary Artery Disease / complications
  • Coronary Artery Disease / surgery
  • Heart Valve Prosthesis Implantation
  • Humans
  • Hydrazones / administration & dosage
  • Hydrazones / adverse effects*
  • Hypertension, Pulmonary / chemically induced*
  • Hypertension, Pulmonary / physiopathology
  • Pulmonary Artery / drug effects*
  • Pulmonary Artery / physiopathology
  • Pyridazines / administration & dosage
  • Pyridazines / adverse effects*
  • Simendan

Substances

  • Cardiotonic Agents
  • Hydrazones
  • Pyridazines
  • Simendan